Gwill York - 06 Feb 2024 Form 4 Insider Report for Alto Neuroscience, Inc. (ANRO)

Role: Director
Signature: /s/ Erin R. McQuade, Attorney-in-Fact
Issuer symbol: ANRO
Transactions as of: 06 Feb 2024
Transactions value $: $0
Form type: 4
Filing time: 07 Feb 2024, 16:41:23 UTC
Previous filing: 05 Feb 2024
Next filing: 06 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANRO	Common Stock	Conversion of derivative security		+23,917			23,917	06 Feb 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANRO	Series A Preferred Stock	Conversion of derivative security	$0	-53,196	-100%	$0^*	0	06 Feb 2024	Common Stock	23,917		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series A Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.2241 for 1 basis and had no expiration date.